<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ateroskleroz</journal-id><journal-title-group><journal-title xml:lang="ru">Атеросклероз</journal-title><trans-title-group xml:lang="en"><trans-title>Ateroscleroz</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-256X</issn><issn pub-type="epub">2949-3633</issn><publisher><publisher-name>НИИТПМ-филиал ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52727/2078-256X-2023-19-3-301-303</article-id><article-id custom-type="elpub" pub-id-type="custom">ateroskleroz-987</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ ВТОРОЙ ВСЕРОССИЙСКОЙ КОНФЕРЕНЦИИ С МЕЖДУНАРОДНЫМ УЧАСТИЕМ «ФУНДАМЕНТАЛЬНЫЕ АСПЕКТЫ АТЕРОСКЛЕРОЗА: НАУЧНЫЕ ИССЛЕДОВАНИЯ ДЛЯ СОВЕРШЕНСТВОВАНИЯ ТЕХНОЛОГИЙ ПЕРСОНАЛИЗИРОВАННОЙ МЕДИЦИНЫ», г. Новосибирск, 12 октября 2023 г.</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MATERIALS OF THE SECOND ALL-RUSSIAN CONFERENCE WITH INTERNATIONAL PARTICIPATION “FUNDAMENTAL ASPECTS OF ATHEROSCLEROSIS: SCIENTIFIC RESEARCH TO IMPROVE TECHNOLOGIES OF PERSONALIZED MEDICINE”, October 12, 2023, Novosibirsk</subject></subj-group></article-categories><title-group><article-title>Влияние курения на уровень белков сурфактанта SP-A и SP-D крови у мужчин и женщин г. Новосибирска</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаев</surname><given-names>К. Ю.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лапицкая</surname><given-names>Я. К.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косарев</surname><given-names>И. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дадашова</surname><given-names>Н. Ф.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Сургут</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>НИИ терапии и профилактической медицины – филиал ФГБНУ ФИЦ ИЦиГ СО РАН</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ФГАОУ ВО «Новосибирский национальный исследовательский государственный университет»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>Сургутский государственный университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2023</year></pub-date><volume>19</volume><issue>3</issue><fpage>301</fpage><lpage>303</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Николаев К.Ю., Лапицкая Я.К., Косарев И.А., Дадашова Н.Ф., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Николаев К.Ю., Лапицкая Я.К., Косарев И.А., Дадашова Н.Ф.</copyright-holder><copyright-holder xml:lang="en">Николаев К.Ю., Лапицкая Я.К., Косарев И.А., Дадашова Н.Ф.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ateroskleroz.elpub.ru/jour/article/view/987">https://ateroskleroz.elpub.ru/jour/article/view/987</self-uri><abstract><p>Введение. Известно, что воздействие табачного дыма, в частности курение сигарет, является основной причиной сердечно-сосудистых заболевания (ССЗ) и сердечно-сосудистых событий у лиц с ССЗ. Сигаретный дым неблагоприятно влияет на функцию эндотелия, способствует развитию атеросклероза и является протромботическим фактором [<xref ref-type="bibr" rid="cit1">1</xref>]. Одним из важных патофизиологических механизмов курения является его влияние на состав и функцию легочного сурфактанта, в частности на белки SP-A и SP-D, выполняющие функцию модулирования иммунной среды легких в ответ на проникновение различных патогенных факторов с минимизацией риска чрезмерной воспалительной реакции [<xref ref-type="bibr" rid="cit2">2</xref>]. Наиболее изучена реакция SP-A и SP-D на сигаретный дым в бронхоальвеолярной жидкости людей и животных, тогда как влияние курения на вышеуказанные сурфактантные белки в крови исследовано недостаточно [<xref ref-type="bibr" rid="cit3">3</xref>]. В связи с этим целью настоящего исследования явилось определение влияния курения на уровень белков сурфактанта SP-A и SP-D крови у мужчин и женщин г. Новосибирска.</p></abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Virani S.S., Newby L.K., Arnold S.V., Bittner V., Brewer L.C., Demeter S.H., Dixon D.L., Fearon W.F., Hess B., Johnson H.M., Kazi D.S., Kolte D., Kumbhani D.J., LoFaso J., Mahtta D., Mark D.B., Minissian M., Navar A.M., Patel A.R., Piano M.R., Rodriguez F., Talbot A.W., Taqueti V.R., Thomas R.J., van Diepen S., Wiggins B., Williams M.S. 2023 AHA/ ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/ American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 2023 Jul 20. doi: 10.1161/CIR.0000000000001168</mixed-citation><mixed-citation xml:lang="en">Virani S.S., Newby L.K., Arnold S.V., Bittner V., Brewer L.C., Demeter S.H., Dixon D.L., Fearon W.F., Hess B., Johnson H.M., Kazi D.S., Kolte D., Kumbhani D.J., LoFaso J., Mahtta D., Mark D.B., Minissian M., Navar A.M., Patel A.R., Piano M.R., Rodriguez F., Talbot A.W., Taqueti V.R., Thomas R.J., van Diepen S., Wiggins B., Williams M.S. 2023 AHA/ ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/ American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 2023 Jul 20. doi: 10.1161/CIR.0000000000001168</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев К.Ю., Харламова О.С., Косарев И.А., Дадашова Н.Ф., Лапицкая Я.К. Белки сурфактанта SP-A, SP-D и конвенциональные факторы риска хронических неинфекционных заболеваний человека. Сиб. науч. мед. журн., 2023; 43 (3): 28–38. doi: 10.18699/SSMJ20230303</mixed-citation><mixed-citation xml:lang="en">Nikolaev K.Yu., Kharlamova O.S., Kosarev I.A., Dadashova N.F., Lapitskaya Ya.K. SP-A and SP-D surfactant proteins and conventional risk factors for chronic noninfectious human diseases. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal, 2023; 43 (3): 28–38. [In Russian]. doi: 10.18699/SSMJ20230303</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Garavaglia M.L., Bodega F., Porta C., Milzani A., Sironi C., Dalle-Donne I. Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant. Int. J. Mol. Sci., 2023 Jul 20; 24 (14): 11702. doi: 10.3390/ijms241411702</mixed-citation><mixed-citation xml:lang="en">Garavaglia M.L., Bodega F., Porta C., Milzani A., Sironi C., Dalle-Donne I. Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant. Int. J. Mol. Sci., 2023 Jul 20; 24 (14): 11702. doi: 10.3390/ijms241411702</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Ríos M., Santiago-Pérez M.I., Alonso B., Malvar A., Hervada X., de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public. Health, 2009 Dec 30; 9: 493. doi: 10.1186/1471-2458-9-493</mixed-citation><mixed-citation xml:lang="en">Pérez-Ríos M., Santiago-Pérez M.I., Alonso B., Malvar A., Hervada X., de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public. Health, 2009 Dec 30; 9: 493. doi: 10.1186/1471-2458-9-493</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z., Chen S., Xu Y., Liu X., Xiong P., Fu Y. Surfactant protein A expression and distribution in human lung samples from smokers with or without chronic obstructive pulmonary disease in China. Medicine (Baltimore), 2020 Feb; 99 (7): e19118. doi: 10.1097/MD.0000000000019118</mixed-citation><mixed-citation xml:lang="en">Liu Z., Chen S., Xu Y., Liu X., Xiong P., Fu Y. Surfactant protein A expression and distribution in human lung samples from smokers with or without chronic obstructive pulmonary disease in China. Medicine (Baltimore), 2020 Feb; 99 (7): e19118. doi: 10.1097/MD.0000000000019118</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mutti A., Corradi M., Goldoni M., Vettori M.V., Bernard A., Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest, 2006 May; 129 (5): 1288–1297. doi: 10.1378/chest.129.5.1288</mixed-citation><mixed-citation xml:lang="en">Mutti A., Corradi M., Goldoni M., Vettori M.V., Bernard A., Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest, 2006 May; 129 (5): 1288–1297. doi: 10.1378/chest.129.5.1288</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ilumets H., Mazur W., Toljamo T., Louhelainen N., Nieminen P., Kobayashi H., Ishikawa N., Kinnula V.L. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm. Med., 2011 Apr 19; 11: 19. doi: 10.1186/1471-2466-11-19</mixed-citation><mixed-citation xml:lang="en">Ilumets H., Mazur W., Toljamo T., Louhelainen N., Nieminen P., Kobayashi H., Ishikawa N., Kinnula V.L. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm. Med., 2011 Apr 19; 11: 19. doi: 10.1186/1471-2466-11-19</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mazur W., Toljamo T., Ohlmeier S., Vuopala K., Nieminen P., Kobayashi H., Kinnula V.L. Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur. Respir. J., 2011 Aug; 38 (2): 277–284. doi: 10.1183/09031936.00110510</mixed-citation><mixed-citation xml:lang="en">Mazur W., Toljamo T., Ohlmeier S., Vuopala K., Nieminen P., Kobayashi H., Kinnula V.L. Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur. Respir. J., 2011 Aug; 38 (2): 277–284. doi: 10.1183/09031936.00110510</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Podolanczuk A.J., Raghu G., Tsai M.Y., Kawut S.M., Peterson E., Sonti R., Rabinowitz D., Johnson C., Barr R.G., Hinckley Stukovsky K., Hoffman E.A., Carr J.J., Ahmed F.S., Jacobs D.R., Watson K., Shea S.J., Lederer D.J. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study. Thorax., 2017 May; 72 (5): 472–474. doi: 10.1136/thoraxjnl-2016-209568</mixed-citation><mixed-citation xml:lang="en">Podolanczuk A.J., Raghu G., Tsai M.Y., Kawut S.M., Peterson E., Sonti R., Rabinowitz D., Johnson C., Barr R.G., Hinckley Stukovsky K., Hoffman E.A., Carr J.J., Ahmed F.S., Jacobs D.R., Watson K., Shea S.J., Lederer D.J. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study. Thorax., 2017 May; 72 (5): 472–474. doi: 10.1136/thoraxjnl-2016-209568</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
